About Jeffrey Abbott
Form D filings for CytoTronics in 2024 list Jeffrey Abbott as chief executive officer and director.
Jeffrey Abbott first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Abbott in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Abbott works with at each company, as listed on that company's latest Form D.
CytoTronics, Inc. · Form D, Oct 11, 2024
SR
Sameer Rohatgi
Director
DK
Douglas Kahn
Director
WW
Wenxuan Wu
Executive officer and director
JA
Jenna Abelli
Director